Atypical hemolytic uremic syndrome
ORPHA:2134DiseaseAutosomal dominant, Autosomal recessive, Not applicableAll ages
Фенотипы (HPO)13
Очень частый (80–99%)8
HP:0000093Proteinuria
HP:0000790Hematuria
HP:0001871Abnormality of blood and blood-forming tissues
HP:0001873Thrombocytopenia
HP:0001919Acute kidney injury
HP:0001937Microangiopathic hemolytic anemia
HP:0001939Abnormality of metabolism/homeostasis
HP:0045040Abnormal lactate dehydrogenase activity
Частый (30–79%)5
HP:0004431Complement deficiency
HP:0005339Abnormality of complement system
HP:0005356Decreased serum complement factor I
HP:0005416Decreased serum complement factor B
HP:0040229Decreased level of thrombomodulin
Эпидемиология3
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.2 | United States | Value and class |
| Point prevalence | 1-9 / 100 000 | 1 | Europe | Value and class |
| Point prevalence | <1 / 1 000 000 | 0.0278 | China | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)